Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology MFM
- Association of conventional cardiovascular risk factors with cardiovascular disease after hypertensive disorders of pregnancy: analysis of the Nord-Trøndelag Health Study.JAMA Cardiol. 2019; 4: 628-635
- Risk of future cardiovascular disease in women with prior preeclampsia: a FOCUS Group Study.BMC Pregnancy Childbirth. 2013; 13: 240
- A history of preeclampsia identifies women who have underlying cardiovascular risk factors.Am J Obstet Gynecol. 2009; 200 (e1–8): 58
- Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births.Lancet. 2001; 357: 2002-2006
- Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study.BMJ. 2001; 323: 1213-1217
- Effect of gestational diabetes and hypertensive disorders of pregnancy on postpartum cardiometabolic risk.Endocr Connect. 2018; 7: 433-442
- Metabolic syndrome following hypertensive disorders in pregnancy in a low-resource setting: a cohort study.Pregnancy Hypertens. 2021; 25: 129-135
- Pre-eclampsia and cardiovascular disease.Cardiovasc Res. 2014; 101: 579-586
- High sensitivity C-reactive protein as a postpartum biomarker for cardiovascular disease risk.J Obstet Gynaecol Can. 2018; 40: 850-851
- Hypertension in pregnancy is associated with elevated C-reactive protein levels later in life.J Hypertens. 2013; 31: 2213-2219
- C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study.Circulation. 2004; 110: 380-385
- Seizing the window of opportunity within 1 year postpartum: early cardiovascular screening.J Am Heart Assoc. 2022; 11e024443
- C-reactive protein, inflammation, and cardiovascular disease: clinical update.Tex Heart Inst J. 2005; 32: 384-386
- Predicting the 30-year risk of cardiovascular disease: the Framingham heart study.Circulation. 2009; 119: 3078-3084
- General cardiovascular risk profile for use in primary care: the Framingham heart study.Circulation. 2008; 117: 743-753
- Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age.Circulation. 2006; 113: 791-798
- IDF Epidemiology Task Force Consensus Group. The metabolic syndrome–a new worldwide definition.Lancet. 2005; 366: 1059-1062
- Chronic hypertension in pregnancy.Am J Obstet Gynecol. 2020; 222: 532-541
- A systematic review of outcomes of maternal weight gain according to the Institute of Medicine Recommendations: birthweight, fetal growth, and postpartum weight retention.Am J Obstet Gynecol. 2009; 201 (e1–14): 339
- Pre-pregnancy body mass index is associated with dietary inflammatory index and C-reactive protein concentrations during pregnancy.Nutrients. 2017; 9: 351
- Maternal obesity and markers of inflammation in pregnancy.Cytokine. 2009; 47: 61-64
- Relationships between pregnancy outcomes, biochemical markers and pre-pregnancy body mass index.Int J Obes (Lond). 2011; 35: 570-577
- Postpartum metabolic syndrome and high-sensitivity C-reactive protein after gestational hypertension and pre-eclampsia.Int J Gynaecol Obstet. 2020; 151: 443-449
- Differences in the prevalence of metabolic syndrome and levels of C-reactive protein after puerperium in women with hypertensive disorders during pregnancy.Hypertens Res. 2010; 33: 1012-1017
- Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction.J Reprod Immunol. 2003; 59: 29-37
- Association of fibrinogen and C-reactive protein with severity of preeclampsia.Eur J Obstet Gynecol Reprod Biol. 2005; 121: 154-158
- Change of hs-CRP, sVCAM-1, NT-proBNP levels in patients with pregnancy-induced hypertension after therapy with magnesium sulfate and nifudipine.Asian Pac J Trop Med. 2013; 6: 897-901
- Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia.Int J Gynaecol Obstet. 2007; 98: 105-109
- OS106. The postpartum preeclampsia clinic (PPPEC) - an interdisciplinary clinic for cardiovascular risk reduction for women with preeclampsia.Pregnancy Hypertens. 2012; 2: 237
- Cardiovascular risk management after a hypertensive disorder of pregnancy.Hypertension. 2012; 60: 1368-1373
- Motivators and barriers to a healthy postpartum lifestyle in women at increased cardiovascular and metabolic risk: a focus-group study.Hypertens Pregnancy. 2012; 31: 147-155
- Pregnancy: a “teachable moment” for weight control and obesity prevention.Am J Obstet Gynecol. 2010; 202 (e1–8): 135
- Does maternal race or ethnicity affect the expression of severe preeclampsia?.Am J Obstet Gynecol. 2005; 193: 973-978
- Racial/ethnic differences in pregnancy-related hypertensive disease in nulliparous women.Ethn Dis. 2014; 24: 283-289
The authors report no conflict of interest.
The Yale Hearts Moms cohort was funded by the Paul Titus Fellowship in Obstetrics, Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine.
The findings of this study were presented as a poster at the annual meeting of the Society for Reproductive Investigation in Denver, CO, March 15-19, 2022.
Cite this article as: Johnstone AM, Pudwell J, Ackerman-Banks CM, et al. High-sensitivity C-reactive protein use in cardiovascular risk screening at 6 to 12 months postpartum following hypertensive disorders of pregnancy. Am J Obstet Gynecol MFM 2022;XX:x.ex–x.ex.